CommercialPrior AuthLow impact
Veregen (sinecatechins ointment)
Blue Cross & Blue Shield of Mississippi·MS · Dermatology, Urology, OB-GYN +2 more·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their Veregen (sinecatechins ointment) policy requiring prior authorization for treatment of external genital and perianal warts. The policy clarifies that patients must fail both podofilox solution AND imiquimod cream before Veregen is considered medically necessary, with a maximum 16-week approval period.
Action Required
Immediately: Billing team must ensure prior authorization is obtained before prescribing Veregen (sinecatechins ointment) for BCBS Mississippi patients. Providers must document failure or intolerance to both podofilox solution AND imiquimod cream. Update prior auth checklists to include these requirements. Claims will be denied without proper prior authorization.